Europe Viscosupplementation Market Size, Share & Industry Trends Analysis Report By Application, By Product (Three Injection, Single Injection, and Five Injection), By End-use, By Country and Growth Forecast, 2023 - 2030

Europe Viscosupplementation Market Size, Share & Industry Trends Analysis Report By Application, By Product (Three Injection, Single Injection, and Five Injection), By End-use, By Country and Growth Forecast, 2023 - 2030


The Europe Viscosupplementation Market would witness market growth of 8.4% CAGR during the forecast period (2023-2030).

The currently available viscosupplements have exhibited clinical efficacy and are recognized as the most effective treatment option for knee osteoarthritis, stimulating market expansion. New products that deliver more effective effects are also being introduced to the market. For instance, during the International Cartilage Regeneration and Joint Preservation Society (ICRS) in June 2019, Anika Therapeutics, Inc. presented Hyalofast, a novel hyaluronic acid-based scaffold for cartilage regeneration.

The knee osteoarthritis sector will also grow due to increasing awareness-raising efforts by public and private organizations. The knee osteoarthritis industry will also grow due to individuals leading more sedentary lifestyles and an increase in the prevalence of knee osteoarthritis in the general population. Numerous factors, including trauma, obesity, and others, contribute to osteoarthritis. The OA affected body parts are afflicted with severe joint pain and stiffness. Osteoarthritis can be identified by symptoms like joint swelling, tingling in the limbs and legs, and decreased range of motion.

According to projections, the EU-27's total population would grow slightly from 446.8 million at the beginning of 2019 to a peak of 449.3 million between 2026 and 2029. By the year 2050, 129.8 million older persons, those who are 65 years of age or older, will live in the EU-27, up from 90.5 million at the beginning of 2019. In the EU-27, it is anticipated that the population between the ages of 75 and 84 will rise by 56.1% during this time, while that between the ages of 65 and 74 is expected to rise by 16.6%. Therefore, the high prevalence of obesity and aging population are expected to increase the growth of the market in the coming years.

The Germany market dominated the Europe Viscosupplementation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $511 million by 2030. The UK market is exhibiting a CAGR of 7.5% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.2% during (2023 - 2030).

Based on Application, the market is segmented into Knee Osteoarthritis, Hand Osteoarthritis, Hip Osteoarthritis, and Others. Based on Product, the market is segmented into Three Injection, Single Injection, and Five Injection. Based on End-use, the market is segmented into Hospitals, and Orthopedic Clinics/ASCs. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include DePuy Synthes (Johnson & Johnson), Sanofi S.A., Zimmer Biomet Holdings, Inc., Ferring Holdings SA, F. Hoffmann-La Roche Ltd., LG Chem Ltd. (LG Corporation), Anika Therapeutics, Inc., Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A), Smith & Nephew PLC and Seikagaku Corp.

Scope of the Study

Market Segments covered in the Report:

By Application
  • Knee Osteoarthritis
  • Hand Osteoarthritis
  • Hip Osteoarthritis
  • Others
By Product
  • Three Injection
  • Single Injection
  • Five Injection
By End-use
  • Hospitals
  • Orthopedic Clinics/ASCs
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • DePuy Synthes (Johnson & Johnson)
  • Sanofi S.A.
  • Zimmer Biomet Holdings, Inc.
  • Ferring Holdings SA
  • F. Hoffmann-La Roche Ltd.
  • LG Chem Ltd. (LG Corporation)
  • Anika Therapeutics, Inc.
  • Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
  • Smith & Nephew PLC
  • Seikagaku Corp.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Viscosupplementation Market, by Application
1.4.2 Europe Viscosupplementation Market, by Product
1.4.3 Europe Viscosupplementation Market, by End-use
1.4.4 Europe Viscosupplementation Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Europe Viscosupplementation Market by Application
4.1 Europe Knee Osteoarthritis Market by Country
4.2 Europe Hand Osteoarthritis Market by Country
4.3 Europe Hip Osteoarthritis Market by Country
4.4 Europe Others Market by Country
Chapter 5. Europe Viscosupplementation Market by Product
5.1 Europe Three Injection Market by Country
5.2 Europe Single Injection Market by Country
5.3 Europe Five Injection Market by Country
Chapter 6. Europe Viscosupplementation Market by End-use
6.1 Europe Hospitals Market by Country
6.2 Europe Orthopedic Clinics/ASCs Market by Country
Chapter 7. Europe Viscosupplementation Market by Country
7.1 Germany Viscosupplementation Market
7.1.1 Germany Viscosupplementation Market by Application
7.1.2 Germany Viscosupplementation Market by Product
7.1.3 Germany Viscosupplementation Market by End-use
7.2 UK Viscosupplementation Market
7.2.1 UK Viscosupplementation Market by Application
7.2.2 UK Viscosupplementation Market by Product
7.2.3 UK Viscosupplementation Market by End-use
7.3 France Viscosupplementation Market
7.3.1 France Viscosupplementation Market by Application
7.3.2 France Viscosupplementation Market by Product
7.3.3 France Viscosupplementation Market by End-use
7.4 Russia Viscosupplementation Market
7.4.1 Russia Viscosupplementation Market by Application
7.4.2 Russia Viscosupplementation Market by Product
7.4.3 Russia Viscosupplementation Market by End-use
7.5 Spain Viscosupplementation Market
7.5.1 Spain Viscosupplementation Market by Application
7.5.2 Spain Viscosupplementation Market by Product
7.5.3 Spain Viscosupplementation Market by End-use
7.6 Italy Viscosupplementation Market
7.6.1 Italy Viscosupplementation Market by Application
7.6.2 Italy Viscosupplementation Market by Product
7.6.3 Italy Viscosupplementation Market by End-use
7.7 Rest of Europe Viscosupplementation Market
7.7.1 Rest of Europe Viscosupplementation Market by Application
7.7.2 Rest of Europe Viscosupplementation Market by Product
7.7.3 Rest of Europe Viscosupplementation Market by End-use
Chapter 8. Company Profiles
8.1 DePuy Synthes (Johnson & Johnson)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental & Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Sanofi S.A.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Zimmer Biomet Holdings, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Ferring Holdings SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research and Development Expense
8.4.5 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 LG Chem Ltd. (LG Corporation)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 SWOT Analysis
8.7 Anika Therapeutics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Smith & Nephew PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional and Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Seikagaku Corp.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings